Skip to content

Cushman & Wakefield

US · CWK #2556 by market cap Listed 2018
11.42 -0.52 -4.36%
Live - 5344 symbols - heartbeat 55s ago · 2026-10-07 19:54
After-hours 11.42 0.00%
Market cap
2.68B
P/B
1.33
EPS
0.38
Reader sentiment Are you bullish or bearish on CWK?

Anonymous reader poll. Unscientific, not investment advice.

Recent news

  • Cushman & Wakefield: Seattle, D.C. Metro and Chicago Recorded the Strongest Growth in Sales Activity Among Leading Metros CWK
    Dow Jones · 2026/9/1
  • Cushman & Wakefield: U.S. Life Sciences Market Is Moving Through Necessary Period of Adjustment as It Absorbs the Significant Amount of Space Delivered in Recent Years CWK
    Dow Jones · 2026/9/1
  • Rating change
    Morgan Stanley Maintains Cushman & Wakefield(CWK.US) With Buy Rating, Raises Target Price to $19
    Market Newswire · 2026/1/17
  • Rating change
    Barclays Maintains Cushman & Wakefield(CWK.US) With Hold Rating, Raises Target Price to $19
    Market Newswire · 2026/1/13
  • Rating change
    Barclays Maintains Cushman & Wakefield(CWK.US) With Hold Rating, Maintains Target Price $15
    Market Newswire · 2026/8/6
  • J.P. Morgan Maintains Cushman & Wakefield(CWK.US) With Hold Rating, Raises Target Price to $19
    Market Newswire · 2026/9/2
  • Cushman & Wakefield: Transaction Activity Remained Concentrated in the Largest Markets, Top Five U.S. Metros Acctg for 81% of Total R&D Deal Volume in 1H CWK
    Dow Jones · 2026/9/1
  • Rating change
    Goldman Sachs Maintains Cushman & Wakefield(CWK.US) With Buy Rating, Raises Target Price to $19
    Market Newswire · 2026/8/19
  • Rating change
    Barclays Maintains Cushman & Wakefield(CWK.US) With Hold Rating, Raises Target Price to $16
    Market Newswire · 2026/8/17
  • Rating change
    Goldman Sachs Maintains Cushman & Wakefield(CWK.US) With Buy Rating, Raises Target Price to $19.5
    Market Newswire · 2026/2/27
  • Rating change
    UBS Maintains Cushman & Wakefield(CWK.US) With Hold Rating, Cuts Target Price to $15
    Market Newswire · 2026/8/10
  • Cushman & Wakefield: Overall U.S. Life Sciences Vacancy Rate Increased From 23.4% at Yr-end 2025 to 24.3% in 2Q CWK
    Dow Jones · 2026/9/1
  • Rating change
    William Blair Maintains Cushman & Wakefield(CWK.US) With Buy Rating
    Market Newswire · 2026/8/6
  • Rating change
    Wolfe Research Upgrades Cushman & Wakefield(CWK.US) to Buy Rating, Announces Target Price $19
    Market Newswire · 2026/2/9
  • Rating change
    Goldman Sachs Maintains Cushman & Wakefield(CWK.US) With Buy Rating, Cuts Target Price to $17
    Market Newswire · 2026/5/22
  • Rating change
    Barclays Maintains Cushman & Wakefield(CWK.US) With Hold Rating, Maintains Target Price $19
    Market Newswire · 2026/2/24
  • Rating change
    Morgan Stanley Maintains Cushman & Wakefield(CWK.US) With Buy Rating, Maintains Target Price $19
    Market Newswire · 2026/8/6
  • Rating change
    Goldman Sachs Maintains Cushman & Wakefield(CWK.US) With Buy Rating, Maintains Target Price $17
    Market Newswire · 2026/6/6
  • Rating change
    J.P. Morgan Maintains Cushman & Wakefield(CWK.US) With Hold Rating, Cuts Target Price to $18
    Market Newswire · 2026/6/3
  • Rating change
    Barclays Maintains Cushman & Wakefield(CWK.US) With Hold Rating, Cuts Target Price to $15
    Market Newswire · 2026/3/13

Headlines are aggregated automatically and are not independently verified or edited by our team.

Quote time 2026-10-07 19:54:59 · For reference only, not investment advice and not tailored to your situation.